Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.

Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000

Eksteen Carla, Riedemann Johann, Rass Atarah M, Plessis Manisha du, Botha Matthys H, van der Merwe Frederick H, Engelbrecht Anna-Mart

Abstract excerpt

Cervical cancer is the fourth most common cancer in women. Advanced stage and metastatic disease are often associated with poor clinical outcomes. This substantiates the absolute necessity for high-throughput diagnostic and treatment platforms that are patient and tumour specific. Cervical cancer treatment constitutes multimodal intervention. Systemic treatments such as chemotherapy and/or focal radiotherapy are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Chemotherapy-induced organ toxicity mitigation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Endometrial and Cervical Cancer Treatments

Share to Mutation

Share to Ovarian cancer diagnosis and treatment

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38881031
DOI: 10.1177/10732748241261539
PMCID: PMC11181891

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.PMID 38881031Read ↗

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.Semantic proximity Read ↗

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.Semantic proximity Read ↗

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor ProgressionSemantic proximity Read ↗

Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic ApproachSemantic proximity Read ↗

Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting ReportSemantic proximity Read ↗

Somatic alterations as the basis for resistance to targeted therapies.Semantic proximity Read ↗

Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug‐resistant pathwaysSemantic proximity Read ↗

The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicineSemantic proximity Read ↗

Systematic Analysis of the Therapy Resistance Genes and their Prognostic Relevance in Cervical CancerSemantic proximity Read ↗

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment OptionsSemantic proximity Read ↗

Drug resistance mechanisms in cancers: Execution of pro-survival strategiesSemantic proximity Read ↗

Genomics and Cancer Drug ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.